Financhill
Sell
43

TNGX Quote, Financials, Valuation and Earnings

Last price:
$8.69
Seasonality move :
-33.38%
Day range:
$8.30 - $8.82
52-week range:
$1.03 - $11.20
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
14.41x
P/B ratio:
7.32x
Volume:
951.3K
Avg. volume:
2.8M
1-year change:
186.18%
Market cap:
$1.2B
Revenue:
$42.1M
EPS (TTM):
-$0.92

Earnings Data

Next earnings date for TNGX
Feb 26
2026
Most recent earnings per share
$0.14
Beat by $0.21
(Nov 4/2025)
Consensus Estimate
-$0.07
(Nov 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

TNGX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/26/2026 Q4 $556K -- -- -$0.33 --
11/04/2025 Q3 $41.2M $53.8M $0.14 -$0.07 $0.21
08/05/2025 Q2 $6.7M $3.2M -$0.35 -$0.34 -$0.01
05/12/2025 Q1 $6.7M $5.4M -$0.36 -$0.35 -$0.02
02/27/2025 Q4 $8M $4.1M -$0.35 -$0.34 -$0.00
11/06/2024 Q3 $8.1M $11.6M -$0.27 -$0.37 $0.11
08/07/2024 Q2 $7.6M $19.9M -$0.24 -$0.35 $0.12
05/08/2024 Q1 $7.5M $6.5M -$0.35 -$0.31 -$0.04
03/18/2024 Q4 $8.2M $5.4M -$0.32 -$0.27 -$0.04
11/08/2023 Q3 -- $10.7M -$0.23 -- --
08/07/2023 Q2 -- $14.6M -$0.23 -- --
05/09/2023 Q1 -- $5.8M -$0.32 -- --
03/27/2023 Q4 -- $6.4M -$0.33 -- --
11/10/2022 Q3 -- $6.9M -$0.33 -- --
08/10/2022 Q2 -- $5.8M -$0.28 -- --
05/11/2022 Q1 -- $5.8M -$0.29 -- --
03/28/2022 Q4 -- $5.7M -$0.25 -- --
11/09/2021 Q3 -- $6.8M -$0.28 -- --
06/30/2021 Q2 -- $18.2M -$0.09 -- --
03/31/2021 Q1 -- $6.4M -$0.29 -- --
12/31/2020 Q4 -- $9.1M -$0.22 -- --
09/30/2020 Q3 -- -$11.3M -$4.76 -- --
06/30/2020 Q2 -- -- -- -- --

Tango Therapeutics, Inc. Earnings Questions

  • How Much did Tango Therapeutics, Inc. Generate in Revenue Last Quarter?

    Tango Therapeutics, Inc. reported $53.8M worth of top line sales in its most recent quarter.

  • Did Tango Therapeutics, Inc. Beat Earnings Last Quarter?

    Tango Therapeutics, Inc. announced earnings per share of $0.14 which represents a beat of analyst forecast a -$0.07 per share.

  • Is Tango Therapeutics, Inc. Profitable?

    Tango Therapeutics, Inc. reported $53.3M that represents $0.48 per share over the last quarter.

  • What is the Analyst Consensus for Tango Therapeutics, Inc. EPS Next Year?

    Tango Therapeutics, Inc.'s earnings are forecast to decrease from -$1.19 per share to -$1.21 per share next year representing a decrease of -24.67%.

  • When is Tango Therapeutics, Inc.'s Earnings Date?

    Tango Therapeutics, Inc.'s next earnings date is February 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock